269 related articles for article (PubMed ID: 3966826)
21. The effects of negative regional lymph-node dissection on survival and disease-free interval of patients with stage-I malignant melanoma.
van Egmond DB; Welvaart K; Hermans J; Ruiter DJ
Neth J Surg; 1990 Apr; 42(2):43-6. PubMed ID: 2348926
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
23. A long-term analysis of 620 patients with malignant melanoma at a major referral center.
Averbook BJ; Russo LJ; Mansour EG
Surgery; 1998 Oct; 124(4):746-55; discussion 755-6. PubMed ID: 9780997
[TBL] [Abstract][Full Text] [Related]
24. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
25. The surgical approach to primary malignant melanoma.
Meyer KL; Kenady DE; Childers SJ
Surg Gynecol Obstet; 1985 Apr; 160(4):379-86. PubMed ID: 3885447
[TBL] [Abstract][Full Text] [Related]
26. Melanoma in children and the use of sentinel lymph node biopsy.
Bütter A; Hui T; Chapdelaine J; Beaunoyer M; Flageole H; Bouchard S
J Pediatr Surg; 2005 May; 40(5):797-800. PubMed ID: 15937817
[TBL] [Abstract][Full Text] [Related]
27. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
[TBL] [Abstract][Full Text] [Related]
28. A clinicopathologic study of prognostic factors in cutaneous malignant melanoma.
Elias EG; Didolkar MS; Goel IP; Formeister JF; Valenzuela LA; Pickren JL; Moore RH
Surg Gynecol Obstet; 1977 Mar; 144(3):327-34. PubMed ID: 841450
[TBL] [Abstract][Full Text] [Related]
29. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
30. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
[TBL] [Abstract][Full Text] [Related]
31. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
32. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis.
Livestro DP; Kaine EM; Michaelson JS; Mihm MC; Haluska FG; Muzikansky A; Sober AJ; Tanabe KK
Cancer; 2007 Aug; 110(3):614-24. PubMed ID: 17577228
[TBL] [Abstract][Full Text] [Related]
33. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs.
Veronesi U; Adamus J; Bandiera DC; Brennhovd IO; Caceres E; Cascinelli N; Claudio F; Ikonopisov RL; Javorskj VV; Kirov S; Kulakowski A; Lacoub J; Lejeune F; Mechl Z; Morabito A; Rodé I; Sergeev S; van Slooten E; Szcygiel K; Trapeznikov NN
N Engl J Med; 1977 Sep; 297(12):627-30. PubMed ID: 895764
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of stage I malignant melanoma].
Fried G; Stein M; Borovik R; Ben Shachar M; Robinson E
Harefuah; 1989 Sep; 117(5-6):130-3. PubMed ID: 2485754
[TBL] [Abstract][Full Text] [Related]
35. [Relation between the prognosis of skin melanomas and the timing of appearance of regional metastases].
Vagner RI; Anisimov VV
Vopr Onkol; 1986; 32(10):21-5. PubMed ID: 3776125
[TBL] [Abstract][Full Text] [Related]
36. Juvenile malignant melanoma.
Reintgen DS; Vollmer R; Seigler HF
Surg Gynecol Obstet; 1989 Mar; 168(3):249-53. PubMed ID: 2919354
[TBL] [Abstract][Full Text] [Related]
37. Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study.
McCarthy WH; Shaw HM; Thompson JF; Milton GW
Surg Gynecol Obstet; 1988 Jun; 166(6):497-502. PubMed ID: 3375961
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of malignant melanoma (clinical stages I and II) (author's transl)].
Tonak J; Hermanek P; Hornstein OP; Weidner F
Dtsch Med Wochenschr; 1976 Mar; 101(12):435-50. PubMed ID: 943283
[TBL] [Abstract][Full Text] [Related]
39. Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion.
Sutherland CM; Mather FJ; Krementz ET
Surg Gynecol Obstet; 1987 Feb; 164(2):111-8. PubMed ID: 3810424
[TBL] [Abstract][Full Text] [Related]
40. [Comparative analysis of narcosis and local anesthesia in surgery of malignant melanoma of the skin].
Seebacher C; Heubaum F; Küster P; Steinert W; Koch R
Hautarzt; 1990 Mar; 41(3):137-41. PubMed ID: 2345097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
